MAGELLAN HEALTH INC 4 SEC Filings

Filed On	Filing
04 Jan 2022	Form 4: Feld Peter A, Director Returned 2,374,798 shares to the issuer
04 Jan 2022	Form 4: West Jeffrey N, SVP & Controller Returned 25,692 shares to the issuer · Disposed of 5,769 Stock Options (Disposition to Issuer) · Disposed of 9,793 Restricted Stock Units (Disposition to Issuer) · 1 more
04 Jan 2022	Form 4: Shulman Steven J, Director Returned 27,451 shares to the issuer
04 Jan 2022	Form 4: Sansone Guy P, Director Returned 7,973 shares to the issuer
04 Jan 2022	Form 4: Norwalk Leslie V, Director Returned 5,698 shares to the issuer
04 Jan 2022	Form 4: Murray James E, President and COO Received 3,262 shares by exercise or conversion · Gave up 871 shares to cover exercise price or tax ($82.7K) · Returned 13,203 shares to the issuer · 3 more
04 Jan 2022	Form 4: Mackenzie Gregory Scott, Director Returned 10,594 shares to the issuer
04 Jan 2022	Form 4: Lewis Clapper Caskie, Chief Human Resources Officer Returned 19,510 shares to the issuer · Disposed of 34,338 Stock Options (Disposition to Issuer) · Disposed of 56,122 Stock Option (Disposition to Issuer) · 2 more
04 Jan 2022	Form 4: Kamal Mostafa, CEO, Magellan Rx Management Returned 5,994 shares to the issuer · Disposed of 51,953 Stock Options (Disposition to Issuer) · Disposed of 37,921 Restricted Stock Units (Disposition to Issuer) · 1 more
04 Jan 2022	Form 4: Josephson Mural R, Director Returned 2,911 shares to the issuer
04 Jan 2022	Form 4: Haddock David, General Counsel & Secretary Returned 2,961 shares to the issuer · Disposed of 19,782 Restricted Stock Units (Disposition to Issuer) · Disposed of 10,605 Performance-Based Restricted Stock Units (Disposition to Issuer)
04 Jan 2022	Form 4: Fasola Kenneth J, Director Returned 17,141 shares to the issuer · Disposed of 73,856 Restricted Stock Units (Disposition to Issuer) · Disposed of 46,154 Performance-Based Restricted Stock Units (Disposition to Issuer)
04 Jan 2022	Form 4: Chen Christopher J, Director Returned 2,911 shares to the issuer
04 Jan 2022	Form 4: Bourdon David, Chief Financial Officer Returned 1,330 shares to the issuer · Disposed of 21,346 Restricted Stock Units (Disposition to Issuer) · Disposed of 4,362 Performance-Based Restricted Stock Units (Disposition to Issuer)
04 Jan 2022	Form 4: Abbott Swati Bargotra, Director Returned 6,847 shares to the issuer
06 Dec 2021	Form 4: Fasola Kenneth J, Director Received 8,580 shares by exercise or conversion · Gave up 3,376 shares to cover exercise price or tax ($319K) · Acquired 8,580 Restricted Stock Units (Option Exercise/Conversion)
05 Oct 2021	Form 4: Bourdon David, Chief Financial Officer Received 2,192 shares by exercise or conversion · Gave up 862 shares to cover exercise price or tax ($81.6K)
17 Aug 2021	Form 4: Feld Peter A, Director Received 789 shares as a grant or award
13 Aug 2021	Form 4: Shulman Steven J, Director Received 789 shares as a grant or award
13 Aug 2021	Form 4: Sansone Guy P, Director Received 789 shares as a grant or award

Comments